A Pilot Study To Evaluate The CreatiVasc Hemoaccess Valve System In Patients Requiring Arteriovenous Graft Placement
Not Applicable
Terminated
- Conditions
- End Stage Renal Disease
- Interventions
- Device: Hemoaccess Valve System
- First Posted Date
- 2012-07-19
- Last Posted Date
- 2018-02-05
- Lead Sponsor
- Diaxamed LLC
- Target Recruit Count
- 6
- Registration Number
- NCT01644526
- Locations
- 🇺🇸
Robert Scribner, Greenville, South Carolina, United States
© Copyright 2025. All Rights Reserved by MedPath